by Shana Cristoferi | Jul 2, 2019 | Appili Therapeutics, News
Appili’s multi-drug resistant antibiotic program has the potential to address public health threats for both military and civilian populations worldwide. HALIFAX, Nova Scotia, July 2, 2019 – Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a...
by Shana Cristoferi | Jun 26, 2019 | Appili Therapeutics, NeuroQuest, News
See full Entrevestor article here Shares of Halifax drug discovery company Appili Therapeutics Inc. begin trading on the TSX Venture exchange today. The company, whose long-term goal is to produce drugs that can combat antibiotic-resistant viruses, issued...
by Shana Cristoferi | Mar 4, 2019 | BioVectra, News
BioVectra Inc. announces a $144.6 million expansion project, including a $37.5 million contribution through the Government of Canada’s Strategic Innovation Fund — Prime Minister Justin Trudeau visits BioVectra to announce Government of Canada investment in...
by administrator | Jan 17, 2019 | BF2030, News
Read original announcement here Nova Scotia startup companies and small and medium-sized businesses will benefit from more investment, thanks to a new Innovation Equity Tax Credit launched today by Finance and Treasury Board Minister Karen Casey. The new tax credit...
by administrator | Jan 8, 2019 | News
BioNova advocates on behalf of the sector for initiatives that are important to attract investment to the province. learn more about the recommendations we’re presenting to Government on modernizing Equity Tax Credits for Atlantic Canada by clicking on the image...
